Back To: Home

Our 2017 Media Kit is now available
Your gateway to the latest oncology news, trends and resources
Inside this issue:
January 2017
MD Anderson and NIH fund trial combining Mesoblast technologies for rapid engraftment of stem cell transplants...
by Mel J. Yeates
January 2017
Illumina kicks off iHope initiative for undiagnosed children...
by Kelsey Kaustinen
January 2017
QGel’s designer matrices promising for organoid culture and cancer therapy development...
by Rachel Flehinger
January 2017
As if human diversity wasn’t tricky enough...
by Randall C Willis
Top Story
December Q&A
As part of the December 2016 issue of DDNews, we have an online-only bonus piece, a Q&A titled "Solosec’s trajectory among antibiotics." In it, Robert Jacks, president and chief financial officer of Symbiomix, discusses briefly with DDNews the company’s product Solosec (secnidazole), a next-generation 5-nitroimidazole antibiotic aimed currently at treating bacterial vaginosis. (Read it now)

Editor's Focus:
January 2017
The big changes still coming, and how to adapt to a changing world.. [ more ]
by Werner Martin of Trajan

January 2017
Life sciences in general, and pharma/biotech along with it, moves fast, and our hats are off to the researchers who are trying to keep pace.. [ more ]
by Randall C Willis

January 2017
Reviewing the past year and highlighting what's to come in DDNews.. [ more ]
by Bruce Poorman/Laurence Doyle

Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by Offenberger & White.